shutterstock_749136616_peshkova
peshkova / Shutterstock.com
1 March 2019Big Pharma

UK court overturns Genentech patent, cites Brexit in CJEU referral

The patents division of the English High Court has  found that a patent owned by Genentech is invalid and  denied the biotechnology company’s application for a supplementary protection certificate (SPC).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
18 February 2020   The English High Court has invalidated key claims of a patent owned by Roche subsidiary Genentech, following a lawsuit filed by US rival Eli Lilly.
Big Pharma
28 August 2020   Genentech and Chugai Pharmaceutical will have to face claims that its haemophilia drug Hemlibra (emicizumab-kxwh) infringed a patent owned by Takeda subsidiary Baxalta.
Big Pharma
8 April 2021   The UK government’s £20 million fund aimed at growing life sciences manufacturing is now open for applications, it confirmed today, April 7.

More on this story

Big Pharma
18 February 2020   The English High Court has invalidated key claims of a patent owned by Roche subsidiary Genentech, following a lawsuit filed by US rival Eli Lilly.
Big Pharma
28 August 2020   Genentech and Chugai Pharmaceutical will have to face claims that its haemophilia drug Hemlibra (emicizumab-kxwh) infringed a patent owned by Takeda subsidiary Baxalta.
Big Pharma
8 April 2021   The UK government’s £20 million fund aimed at growing life sciences manufacturing is now open for applications, it confirmed today, April 7.

More on this story

Big Pharma
18 February 2020   The English High Court has invalidated key claims of a patent owned by Roche subsidiary Genentech, following a lawsuit filed by US rival Eli Lilly.
Big Pharma
28 August 2020   Genentech and Chugai Pharmaceutical will have to face claims that its haemophilia drug Hemlibra (emicizumab-kxwh) infringed a patent owned by Takeda subsidiary Baxalta.
Big Pharma
8 April 2021   The UK government’s £20 million fund aimed at growing life sciences manufacturing is now open for applications, it confirmed today, April 7.